FDA Cannot Regulate Stem Cell Treatments, DC Circ. Hears
Regenerative Sciences LLC on Monday blasted the U.S. Food and Drug Administration's attempt to regulate its stem cell treatments as a drug, telling a D.C. Circuit panel that the agency doesn't...To view the full article, register now.
Already a subscriber? Click here to view full article